Novo Holdings sees golden opportunity in dialysis company, contributes to USD 245m investment
Novo Holdings has coinvested alongside a group of current and new investors in Quantra Dialysis Technologies, who are injecting a total of USD 245m into the UK-based firm.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
It seemed as though Novo Holdings had ended the first half of 2021 with a bang, when it purchased diagnostics firm BBI Group last week, but the company has pulled out its checkbook again in a final flourish for the quarter.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Novo Nordisk expands collaboration with US app company
For subscribers
Novo Holdings plans to enter China
For subscribers
